Neha Gupta, B.D.S., D.M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Carcinoma, Basal Cell | 3 | 2023 | 545 | 0.860 |
Why?
|
Sweat Glands | 1 | 2022 | 31 | 0.840 |
Why?
|
Eyelid Neoplasms | 1 | 2023 | 94 | 0.830 |
Why?
|
Dermatology | 4 | 2022 | 872 | 0.700 |
Why?
|
Skin Neoplasms | 5 | 2023 | 5686 | 0.620 |
Why?
|
Carcinoma, Squamous Cell | 2 | 2023 | 4034 | 0.580 |
Why?
|
Hyperbilirubinemia | 1 | 2015 | 77 | 0.530 |
Why?
|
Glucuronosyltransferase | 1 | 2015 | 128 | 0.520 |
Why?
|
RNA Splice Sites | 1 | 2015 | 209 | 0.500 |
Why?
|
Carcinoma | 1 | 2022 | 2375 | 0.370 |
Why?
|
Exons | 1 | 2015 | 2437 | 0.350 |
Why?
|
Appointments and Schedules | 2 | 2020 | 417 | 0.270 |
Why?
|
Genome, Viral | 2 | 2019 | 667 | 0.250 |
Why?
|
Promoter Regions, Genetic | 1 | 2015 | 5867 | 0.240 |
Why?
|
Quackery | 1 | 2021 | 6 | 0.210 |
Why?
|
Internship and Residency | 1 | 2022 | 5788 | 0.210 |
Why?
|
Parainfluenza Virus 1, Human | 1 | 2019 | 28 | 0.180 |
Why?
|
Parainfluenza Virus 3, Human | 1 | 2019 | 24 | 0.180 |
Why?
|
Neoplasm Staging | 3 | 2023 | 11031 | 0.170 |
Why?
|
Equipment and Supplies | 1 | 2021 | 281 | 0.170 |
Why?
|
Hair | 1 | 2021 | 483 | 0.160 |
Why?
|
Adenovirus Infections, Human | 1 | 2018 | 71 | 0.150 |
Why?
|
Alopecia | 1 | 2021 | 382 | 0.150 |
Why?
|
Hedgehog Proteins | 1 | 2022 | 783 | 0.140 |
Why?
|
Adrenergic beta-Antagonists | 2 | 2021 | 1240 | 0.140 |
Why?
|
Commerce | 1 | 2021 | 592 | 0.140 |
Why?
|
Adenoviruses, Human | 1 | 2018 | 257 | 0.140 |
Why?
|
Schools, Medical | 1 | 2022 | 880 | 0.130 |
Why?
|
Waiting Lists | 1 | 2020 | 692 | 0.130 |
Why?
|
Office Visits | 1 | 2019 | 598 | 0.130 |
Why?
|
Prognosis | 4 | 2023 | 29063 | 0.130 |
Why?
|
Radiotherapy | 1 | 2022 | 1533 | 0.120 |
Why?
|
Lymphatic Metastasis | 1 | 2022 | 2924 | 0.120 |
Why?
|
Homozygote | 2 | 2015 | 1785 | 0.120 |
Why?
|
Bilirubin | 1 | 2015 | 425 | 0.120 |
Why?
|
Neoplasm Invasiveness | 1 | 2022 | 3616 | 0.120 |
Why?
|
Organ Transplantation | 1 | 2023 | 1139 | 0.110 |
Why?
|
Genomics | 2 | 2019 | 5720 | 0.110 |
Why?
|
Lymph Nodes | 2 | 2023 | 3474 | 0.100 |
Why?
|
Heterozygote | 2 | 2015 | 2804 | 0.100 |
Why?
|
DNA, Viral | 1 | 2018 | 2225 | 0.100 |
Why?
|
Income | 1 | 2019 | 1913 | 0.090 |
Why?
|
Education, Medical, Graduate | 1 | 2022 | 2291 | 0.090 |
Why?
|
Surgical Procedures, Operative | 1 | 2022 | 1876 | 0.090 |
Why?
|
Combined Modality Therapy | 1 | 2022 | 8642 | 0.090 |
Why?
|
India | 1 | 2015 | 2197 | 0.090 |
Why?
|
Humans | 21 | 2023 | 744343 | 0.090 |
Why?
|
Internet | 1 | 2021 | 3064 | 0.090 |
Why?
|
Incidental Findings | 1 | 2014 | 689 | 0.090 |
Why?
|
Stroke Volume | 2 | 2021 | 5007 | 0.090 |
Why?
|
Retrospective Studies | 5 | 2023 | 77449 | 0.080 |
Why?
|
Hospitals | 1 | 2021 | 3952 | 0.080 |
Why?
|
Insurance, Health | 1 | 2020 | 2494 | 0.080 |
Why?
|
Heart Rate | 1 | 2018 | 4091 | 0.070 |
Why?
|
Mutation, Missense | 1 | 2015 | 2564 | 0.070 |
Why?
|
Heart Failure | 2 | 2021 | 10900 | 0.070 |
Why?
|
Polymorphism, Single Nucleotide | 2 | 2015 | 15519 | 0.070 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2014 | 1519 | 0.060 |
Why?
|
Cholera | 1 | 2011 | 785 | 0.060 |
Why?
|
Communicable Disease Control | 1 | 2011 | 857 | 0.060 |
Why?
|
Cross-Sectional Studies | 2 | 2022 | 25043 | 0.060 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2022 | 9239 | 0.060 |
Why?
|
Recombination, Genetic | 2 | 2019 | 1586 | 0.060 |
Why?
|
Philadelphia | 1 | 2023 | 266 | 0.060 |
Why?
|
Health Services Accessibility | 1 | 2020 | 5137 | 0.050 |
Why?
|
Cohort Studies | 2 | 2023 | 40561 | 0.050 |
Why?
|
Adenocarcinoma | 1 | 2019 | 6364 | 0.050 |
Why?
|
Ohio | 1 | 2022 | 337 | 0.050 |
Why?
|
Disease Outbreaks | 1 | 2011 | 1772 | 0.050 |
Why?
|
Algorithms | 3 | 2020 | 13881 | 0.050 |
Why?
|
Phylogeny | 2 | 2019 | 2803 | 0.050 |
Why?
|
Fraud | 1 | 2021 | 67 | 0.050 |
Why?
|
Genome, Human | 1 | 2014 | 4420 | 0.050 |
Why?
|
Mutation | 2 | 2015 | 29786 | 0.050 |
Why?
|
Colorectal Neoplasms | 1 | 2019 | 6773 | 0.040 |
Why?
|
Evolution, Molecular | 2 | 2019 | 1940 | 0.040 |
Why?
|
Antineoplastic Agents | 1 | 2022 | 13695 | 0.040 |
Why?
|
Ventricular Function, Right | 1 | 2021 | 591 | 0.040 |
Why?
|
Geography | 1 | 2019 | 669 | 0.040 |
Why?
|
Sequence Analysis, DNA | 2 | 2019 | 4803 | 0.040 |
Why?
|
Telephone | 1 | 2019 | 617 | 0.030 |
Why?
|
Family Characteristics | 1 | 2019 | 1000 | 0.030 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2019 | 3597 | 0.030 |
Why?
|
Selection, Genetic | 1 | 2019 | 914 | 0.030 |
Why?
|
Female | 4 | 2022 | 380194 | 0.030 |
Why?
|
Observer Variation | 1 | 2019 | 2593 | 0.030 |
Why?
|
Adolescent | 2 | 2022 | 85781 | 0.030 |
Why?
|
Educational Status | 1 | 2019 | 2540 | 0.030 |
Why?
|
Molecular Sequence Annotation | 1 | 2014 | 528 | 0.030 |
Why?
|
False Positive Reactions | 1 | 2014 | 981 | 0.030 |
Why?
|
Mutagenesis, Insertional | 1 | 2014 | 655 | 0.020 |
Why?
|
Propensity Score | 1 | 2018 | 1781 | 0.020 |
Why?
|
Logistic Models | 2 | 2018 | 13408 | 0.020 |
Why?
|
Young Adult | 1 | 2015 | 56430 | 0.020 |
Why?
|
Haiti | 1 | 2011 | 553 | 0.020 |
Why?
|
Neoplasm Metastasis | 1 | 2019 | 4851 | 0.020 |
Why?
|
Male | 4 | 2022 | 350118 | 0.020 |
Why?
|
Time Factors | 2 | 2020 | 40075 | 0.020 |
Why?
|
Base Sequence | 1 | 2018 | 12797 | 0.020 |
Why?
|
Pedigree | 1 | 2014 | 4644 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2018 | 10943 | 0.020 |
Why?
|
Adult | 2 | 2019 | 214055 | 0.020 |
Why?
|
Computational Biology | 1 | 2018 | 3521 | 0.020 |
Why?
|
Genotype | 1 | 2018 | 12951 | 0.010 |
Why?
|
Disease Progression | 1 | 2019 | 13284 | 0.010 |
Why?
|
United States | 2 | 2021 | 69872 | 0.010 |
Why?
|
Hospitalization | 1 | 2021 | 10262 | 0.010 |
Why?
|
Middle Aged | 1 | 2015 | 213383 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2019 | 19905 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2014 | 16689 | 0.010 |
Why?
|
Risk Factors | 1 | 2023 | 72290 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2018 | 57776 | 0.010 |
Why?
|
Incidence | 1 | 2011 | 20947 | 0.010 |
Why?
|
Aged | 1 | 2018 | 163280 | 0.000 |
Why?
|